This guide introduces a powerful, synergistic protocol that is gaining significant traction in functional medicine: the combination of Low-Dose Naltrexone (LDN) and specific therapeutic peptides
Angiogenesis, wound-repair, and preclinical systemic effects In preclinical models, GHK-Cu promotes angiogenesis (new blood-vessel formation), attracts repair cells such as macrophages and capillary cells to injury sites, and accelerates wound healing across a range of tissues and species skin, hair follicles, gastrointestinal lining, bone, and more
His combination has since been named the Myers Cocktail and has gained national recognition
Cytokine-directed therapies targeting inflammation have also demonstrated potential in preserving cell function and improving glycemic control
What is the difference between the vial and the pen version